Abstract | BACKGROUND: Radiation recall pneumonitis describes a very rare reaction in a previously irradiated area of pulmonary tissue after application of pharmacological agents. A case of recall pneumonitis induced by gemcitabine is reported. CASE REPORT: A 64-year-old female patient with metastasized esophageal carcinoma received simultaneous chemoradiotherapy of the upper mediastinum with 50.4 Gy and cisplatin/ 5-fluorouracil. 8 months later she was scheduled for salvage chemotherapy with gemcitabine (1,000 mg/m(2) days 1 and 8) and docetaxel (75 mg/m(2) day 8) due to locally progressive disease. After having received gemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and dyspnea within 48 h. A CT of the thorax revealed newly developed bilateral pulmonary ground-glass opacity corresponding to the previous radiation fields. Chemotherapy was stopped and systemic application of prednisolone was initiated. 2 months later symptoms had resolved with a control CT of the thorax showing complete regression of the pulmonary changes. CONCLUSION:
|
Authors | Sebastian Schwarte, Katharina Wagner, Johann H Karstens, Michael Bremer |
Journal | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(Strahlenther Onkol)
Vol. 183
Issue 4
Pg. 215-7
(Apr 2007)
ISSN: 0179-7158 [Print] Germany |
PMID | 17406804
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antimetabolites, Antineoplastic
- Deoxycytidine
- Gemcitabine
|
Topics |
- Antimetabolites, Antineoplastic
(adverse effects)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Combined Modality Therapy
- Deoxycytidine
(adverse effects, analogs & derivatives)
- Esophageal Neoplasms
(drug therapy, pathology, radiotherapy)
- Female
- Humans
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Metastasis
- Pneumonia
(chemically induced, diagnostic imaging)
- Radionuclide Imaging
- Treatment Outcome
- Gemcitabine
|